Director Goldman Jonathan sold Avalo Therapeutics ($AVTX) shares on the open market twice in the last year, for a total of about $163 thousand. His most recent sale occurred on November 14, 2025. These sales rank 8,836th among 11,678 insiders in our database, where the average is $8.6 million across 6.4 transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 28, 2026 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Not found | M | Common Stock | 3166 | $0.00 | 3,166.0000 | 18,133,968 | 9999.99% | 0.02% |
| March 28, 2026 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Not found | M | Restricted Stock Units | 3166 | $0.00 | 3,167.0000 | 18,133,968 | 49.99% | 0.02% |
| Nov. 14, 2025 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | S | Common Stock | 3167 | $14.30 | 0.0000 | 18,133,968 | 100.00% | 0.02% |
| Nov. 14, 2025 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | M | Common Stock | 8200 | $9.88 | 8,200.0000 | 18,133,968 | 9999.99% | 0.05% |
| Nov. 14, 2025 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | S | Common Stock | 8200 | $14.35 | 0.0000 | 18,133,968 | 100.00% | 0.05% |
| Nov. 14, 2025 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | M | Stock Option (Right to Buy) | 8200 | $0.00 | 16,400.0000 | 18,133,968 | 33.33% | 0.05% |
| June 17, 2025 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | A | Stock Option (Right to Buy) | 20100 | $0.00 | 20,100.0000 | 10,671,934 | 9999.99% | 0.19% |
| March 28, 2025 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | M | Common Stock | 3167 | $0.00 | 3,167.0000 | 10,671,934 | 9999.99% | 0.03% |
| March 28, 2025 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | M | Restricted Stock Units | 3167 | $0.00 | 6,333.0000 | 10,671,934 | 33.34% | 0.03% |
| Aug. 13, 2024 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | A | Stock Option (Right to Buy) | 24600 | $0.00 | 24,600.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Avalo Therapeutics, Inc. | $AVTX | Goldman Jonathan | Director | A | Restricted Stock Units | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |